Please provide your email address to receive an email when new articles are posted on . The world’s first dual-chamber leadless pacing system was named a top invention of 2023. The first implantation ...

A new injectable, temporary pacemaker could help correct a heart arrhythmia in an emergency. This nanoparticle gel can regulate the heart’s electrical signals for up to five days before dissolving ...

California and Florida have the most top-ranked hospitals for pacemaker or defibrillator placement in the U.S., according to the WebMD Choice Awards. WebMD and Medscape partnered to recognize U.S.

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...

While modern pacemakers have proven an invaluable and lifesaving medical tool, the way they regulate the pace of the heart differs from the varying beat of the organ in a healthy individual.

Roughly one percent of infants are born with heart defects every year. The majority of these cases only require a temporary implant for about seven days to allow time for the heart to naturally ...

The world’s tiniest pacemaker — smaller than a grain of rice — could help save babies born with heart defects, say scientists. The miniature device can be inserted with a syringe and dissolves after ...

Pacemakers, relied upon by many patients with irregular heart rhythms, are not built for children. Scrambling up trees, hanging from monkey bars, and even the simple act of growing make the device ...

Researchers at Northwestern University just found a way to make a temporary pacemaker that’s controlled by light—and it’s smaller than a grain of rice. A study on the new device, published last week ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved pacemakers with automatic MRI field sensing functionality. This feature is designed to ...

The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.